Open AccessNeuroleptic malignant syndrome associated with haloperidol treatment in a patient with head injury
Author(s) -
Han-Lin Yen,
ShihChuan Tsai
Publication year - 2013
Publication title -
formosan journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 8
eISSN - 2213-5413
pISSN - 1682-606X
DOI - 10.1016/j.fjs.2013.03.003
Subject(s) - haloperidol , medicine , neuroleptic malignant syndrome , dysautonomia , anesthesia , antipsychotic , traumatic brain injury , closed head injury , head injury , antipsychotic drug , surgery , psychiatry , schizophrenia (object oriented programming) , disease , dopamine
SummaryNeuroleptic malignant syndrome (NMS) is a rare disorder that manifests with rigidity, fever, dysautonomia, and changes in mental status. Haloperidol, an atypical antipsychotic drug, has reportedly been used to treat agitation in patients with traumatic brain injury (TBI). We herein present the case of a patient with TBI and agitation who, having received haloperidol, developed NMS. The syndrome was successfully treated with supportive care and cessation of haloperidol administration